Literature DB >> 23616149

Associations of total and undercarboxylated osteocalcin with peripheral and hepatic insulin sensitivity and β-cell function in overweight adults.

Barbara A Gower1, Norman K Pollock, Krista Casazza, Thomas L Clemens, Laura Lee Goree, Wesley M Granger.   

Abstract

CONTEXT: Animal studies indicate that osteocalcin (OC), particularly the undercarboxylated isoform (unOC), affects insulin sensitivity and secretion, but definitive data from humans are lacking.
OBJECTIVE: The objectives of the study were to determine whether total OC and unOC are independently associated with insulin sensitivity and β-cell response in overweight/obese adults; whether glucose tolerance status affects these associations; and whether the associations are independent of bone formation, as reflected in procollagen type 1 amino propeptide (P1NP). DESIGN, SETTING, AND PARTICIPANTS: This was a cross-sectional study conducted at a university research center involving 63 overweight/obese adults with normal (n = 39) or impaired fasting glucose (IFG; n = 24). MAIN OUTCOME MEASURES: Serum concentrations of total/undercarboxylated OC and P1NP were assessed by RIA; insulin sensitivity was determined by iv glucose tolerance test (S(I)-IVGTT), liquid meal test (S(I) meal), and homeostasis model assessment of insulin resistance; β-cell response to glucose [basal β-cell response to glucose; dynamic β-cell response to glucose; static β-cell response to glucose; and total β-cell response to glucose] was derived using C-peptide modeling of meal test data; and intraabdominal adipose tissue was measured using computed tomography scanning.
RESULTS: Multiple linear regression, adjusting for intraabdominal adipose tissue and P1NP, revealed that total OC was positively associated with S(I)-iv glucose tolerance test (P < .01) in the total sample. OC was not associated with S(I) meal or homeostasis model assessment of insulin resistance. In participants with IFG, unOC was positively associated with static β-cell response to glucose and total β-cell response to glucose (P < .05), independent of insulin sensitivity.
CONCLUSIONS: In overweight/obese individuals, total OC may be associated with skeletal muscle but not hepatic insulin sensitivity. unOC is uniquely associated with β-cell function only in individuals with IFG. Further research is needed to probe the causal inference of these relationships and to determine whether indirect nutrient sensing pathways underlie these associations.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23616149      PMCID: PMC3701277          DOI: 10.1210/jc.2013-1203

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  35 in total

Review 1.  Use and abuse of HOMA modeling.

Authors:  Tara M Wallace; Jonathan C Levy; David R Matthews
Journal:  Diabetes Care       Date:  2004-06       Impact factor: 19.112

2.  A reduced serum level of total osteocalcin in men predicts the development of diabetes in a long-term follow-up cohort.

Authors:  Chardpraorn Ngarmukos; La-or Chailurkit; Suwanee Chanprasertyothin; Bunlue Hengprasith; Piyamitr Sritara; Boonsong Ongphiphadhanakul
Journal:  Clin Endocrinol (Oxf)       Date:  2012-07       Impact factor: 3.478

3.  Lower uncarboxylated osteocalcin concentrations in children with prediabetes is associated with beta-cell function.

Authors:  Norman K Pollock; Paul J Bernard; Barbara A Gower; Caren M Gundberg; Karl Wenger; Sudipta Misra; Reda W Bassali; Catherine L Davis
Journal:  J Clin Endocrinol Metab       Date:  2011-04-20       Impact factor: 5.958

4.  Effects of physiological variations in circulating insulin levels on bone turnover in humans.

Authors:  Rita Basu; James Peterson; Robert Rizza; Sundeep Khosla
Journal:  J Clin Endocrinol Metab       Date:  2011-02-16       Impact factor: 5.958

5.  Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

Authors:  M Matsuda; R A DeFronzo
Journal:  Diabetes Care       Date:  1999-09       Impact factor: 19.112

6.  Serum concentrations of carboxylated osteocalcin are increased and associated with several components of the polycystic ovarian syndrome.

Authors:  Evanthia Diamanti-Kandarakis; Sarantis Livadas; Ilias Katsikis; Christine Piperi; Aimilia Mantziou; Mantziou Aimilia; Athanasios G Papavassiliou; Dimitrios Panidis
Journal:  J Bone Miner Metab       Date:  2010-08-07       Impact factor: 2.626

7.  Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity.

Authors:  Elisa Fabbrini; Faidon Magkos; B Selma Mohammed; Terri Pietka; Nada A Abumrad; Bruce W Patterson; Adewole Okunade; Samuel Klein
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-24       Impact factor: 11.205

8.  The insulin sensitivity index in nondiabetic man. Correlation between clamp-derived and IVGTT-derived values.

Authors:  J C Beard; R N Bergman; W K Ward; D Porte
Journal:  Diabetes       Date:  1986-03       Impact factor: 9.461

9.  Vitamin K status and bone health: an analysis of methods for determination of undercarboxylated osteocalcin.

Authors:  C M Gundberg; S D Nieman; S Abrams; H Rosen
Journal:  J Clin Endocrinol Metab       Date:  1998-09       Impact factor: 5.958

10.  Plasma osteocalcin is inversely related to fat mass and plasma glucose in elderly Swedish men.

Authors:  Jenny M Kindblom; Claes Ohlsson; Osten Ljunggren; Magnus K Karlsson; Asa Tivesten; Ulf Smith; Dan Mellström
Journal:  J Bone Miner Res       Date:  2009-05       Impact factor: 6.741

View more
  20 in total

1.  Increased Gs Signaling in Osteoblasts Reduces Bone Marrow and Whole-Body Adiposity in Male Mice.

Authors:  Corey J Cain; Joel T Valencia; Samantha Ho; Kate Jordan; Aaron Mattingly; Blanca M Morales; Edward C Hsiao
Journal:  Endocrinology       Date:  2016-02-22       Impact factor: 4.736

Review 2.  Insulin and bone: Recent developments.

Authors:  Gordon L Klein
Journal:  World J Diabetes       Date:  2014-02-15

Review 3.  Bone as an endocrine organ relevant to diabetes.

Authors:  Sarah L Booth; Amanda J Centi; Caren Gundberg
Journal:  Curr Diab Rep       Date:  2014-12       Impact factor: 4.810

Review 4.  Childhood obesity, bone development, and cardiometabolic risk factors.

Authors:  Norman K Pollock
Journal:  Mol Cell Endocrinol       Date:  2015-03-27       Impact factor: 4.102

Review 5.  The role of osteoblasts in energy homeostasis.

Authors:  Naomi Dirckx; Megan C Moorer; Thomas L Clemens; Ryan C Riddle
Journal:  Nat Rev Endocrinol       Date:  2019-08-28       Impact factor: 43.330

Review 6.  The role of the musculoskeletal system in post-burn hypermetabolism.

Authors:  Gordon L Klein
Journal:  Metabolism       Date:  2019-06-08       Impact factor: 8.694

7.  Osteocalcin protects against nonalcoholic steatohepatitis in a mouse model of metabolic syndrome.

Authors:  Anisha A Gupte; Omaima M Sabek; Daniel Fraga; Laurie J Minze; Satoru K Nishimoto; Joey Z Liu; Solmaz Afshar; Lillian Gaber; Christopher J Lyon; A Osama Gaber; Willa A Hsueh
Journal:  Endocrinology       Date:  2014-10-03       Impact factor: 4.736

Review 8.  New insights into the biology of osteocalcin.

Authors:  Meredith L Zoch; Thomas L Clemens; Ryan C Riddle
Journal:  Bone       Date:  2015-06-06       Impact factor: 4.398

9.  Increasing adiposity is associated with higher adipokine levels and lower bone mineral density in obese older adults.

Authors:  Lina Aguirre; Nicola Napoli; Debra Waters; Clifford Qualls; Dennis T Villareal; Reina Armamento-Villareal
Journal:  J Clin Endocrinol Metab       Date:  2014-05-30       Impact factor: 5.958

10.  Osteoprotegerin is a Better Serum Biomarker of Coronary Artery Calcification than Osteocalcin in Type 2 Diabetes.

Authors:  Raelene E Maser; M James Lenhard; Michael B Sneider; Ryan T Pohlig
Journal:  Endocr Pract       Date:  2015-01       Impact factor: 3.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.